rxstat › Shortages › Hydrochlorothiazide Candesartan Cilexetil

Hydrochlorothiazide Candesartan Cilexetil shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Hydrochlorothiazide Candesartan Cilexetil products are in shortage in Canada (4 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 31, 2026.
Products affected
4 / 21
In shortage since
Sep 18, 2024
Est. full return
Aug 31, 2026
Reports on file
86
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
SANDOZ CANDESARTAN PLUS
12.5MG 32MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02420732 · since Jun 29, 2026, est. end Aug 28, 2026 · Demand increase for the drug.
Active shortage
AURO-CANDESARTAN HCT
32MG 25MG · TABLET · AURO PHARMA INC
DIN 02421054 · since Jun 18, 2026, est. end Aug 31, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
TEVA-CANDESARTAN/HCTZ
12.5MG 16MG · TABLET · TEVA CANADA LIMITED
DIN 02395541 · since Sep 18, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CANDESARTAN/HCTZ
12.5MG 32MG · TABLET · TEVA CANADA LIMITED
DIN 02395568 · since Jul 31, 2025, no end estimate · Disruption of the manufacture of the drug.
Resolved
SANDOZ CANDESARTAN PLUS
25MG 32MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02420740 · ended Jun 8, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CANDESARTAN PLUS
32MG 12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02420732 · ended Jun 8, 2026 · Demand increase for the drug.
Resolved
SANDOZ CANDESARTAN PLUS
32MG 12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02420732 · ended May 4, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CANDESARTAN PLUS
16MG 12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02327902 · ended Apr 6, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ CANDESARTAN PLUS
16MG 12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02327902 · ended Mar 30, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CANDESARTAN PLUS
32MG 12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02420732 · ended Mar 9, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CANDESARTAN PLUS
12.5MG 16MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02327902 · ended Mar 9, 2026 · Disruption of the manufacture of the drug.
Resolved
CANDESARTAN/HCTZ
12.5MG 16MG · TABLET · SANIS HEALTH INC
DIN 02394804 · ended Apr 1, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Hydrochlorothiazide Candesartan Cilexetil is currently affected by 4 active shortage reports filed with Health Canada by SANDOZ CANADA INCORPORATED, AURO PHARMA INC, TEVA CANADA LIMITED.

The reported causes are: demand increase for the drug; requirements related to complying with good manufacturing practices; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Hydrochlorothiazide Candesartan Cilexetil is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DA).

Recent changes

Common questions

When will Hydrochlorothiazide Candesartan Cilexetil be back in stock in Canada?

The latest manufacturer estimate is Aug 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Hydrochlorothiazide Candesartan Cilexetil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (angiotensin ii antagonists, combinations)

Partial shortageAmlodipine Telmisartan2 of 6 reported products affectedPartial shortageHydrochlorothiazide Irbesartan13 of 35 reported products affected · est. return Dec 4, 2026Partial shortageHydrochlorothiazide Losartan3 of 35 reported products affected · est. return Jul 7, 2026Partial shortageHydrochlorothiazide Valsartan5 of 27 reported products affected · est. return Jul 31, 2026Partial shortageOlmesartan Medoxomil Hydrochlorothiazide6 of 24 reported products affectedPartial shortageTelmisartan Hydrochlorothiazide3 of 23 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.